Vorsitzende: M. Böhm (Homburg/Saar), J. Mann (München)
| (SY1349) | Pathophysiology of RAS and cardiovascular risk |
|
|
M. Böhm (Homburg/Saar) |
| (SY1350) |
Metabolic syndrome in the hypertensive patient |
|
|
T. Unger (Berlin) |
| (SY1351) | The cardio renal connection - Improving CV outcomes by early intervention in renal disease |
|
|
R. E. Schmieder (Erlangen) |
| (SY1352) |
The Future of RAS blockade – What comes after HOPE, ONTARGET and TRANSCEND?
|
|
|
S. Yusuf (Hamilton, CA) |